Health & Biotech
Check out the latest Cannabis news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
News
ASX Small Cap Lunch Wrap: Today’s high flyers and sinking ships
Health & Biotech
ECS Botanics flags major initiative to make Tasmania the ‘global epicentre’ of medical cannabis production
Health & Biotech
Biotech Avecho just got the all-clear for human cannabis trials
Health & Biotech
Virginia first southern US state to legalise cannabis, ASX-listed Medlab gets first nod from Europe patent office
Health & Biotech
Weed Week: Australian medical cannabis prescriptions are soaring
Health & Biotech
It looks like 2021 will be the Year of Cannabis Legalisation in the US
Energy
Asia could look to Australia for biofuels as region’s demand increases
Health & Biotech
NY finally on cannabis bandwagon, as ASX-listed Creso Pharma boosts coffers by $18 million
Health & Biotech
Cann Group, Emyria team up in bid to gain TGA approval for low-dose CBD gelcap
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
MGC Pharmaceuticals receives go-ahead for Phase III trial of COVID-19 treatment
Health & Biotech
Creso Pharma to pursue dual listing in USA and announces new psilocybin supplies
Health & Biotech
US cannabis market gets major boost as SAFE Act is put in front of legislators once again
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Huge shakeup expected as British American Tobacco makes a move on Canadian cannabis
Health & Biotech
$15 million in Australian grant funding vindicates Creso’s jump into psychedelics
Health & Biotech
Incannex will pursue a SIXTH possible use for its experimental drug cocktail: treating rheumatoid arthritis
Health & Biotech
Strategic moves in cannabis – ECS’s giant leapfrog puts it ahead of the game
Health & Biotech
Good luck Chuck – Schumer’s ‘bold agenda’ email confirms legalisation’s time is nigh
Health & Biotech
Elixinol the latest pot stock to M&A; recruits German media entrepreneur to its board
Health & Biotech
Creso Pharma Q&A: Halucenex Life Sciences acquisition
Stockhead TV
Creso Pharma’s acquisition of Halucenex Life Sciences marks the first fully-owned psychedelic medicines company on the ASX
Health & Biotech
Creso Pharma enters psychedelics market with ‘transformational’ Canadian acquisition
Health & Biotech
Incannex teams up with Monash University and the NFL in exciting new study for its proprietary concussion treatment
Health & Biotech
Creso Pharma signs second North American distribution partner
Health & Biotech
ECS Botanics integrates vertically with acquisition of Murray Meds
Health & Biotech
Normal service is resuming for pot stocks as WSB buzz dies down
Health & Biotech
Creso Pharma makes plans to enter US market with new partnership
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
MGC Pharma strikes exclusive world-wide product distribution agreement
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Creso Pharma’s Canadian subsidiary gets four more cannabis orders totalling $500k
Health & Biotech
Huge potential for tiny Perth company’s autism treatment candidate
Health & Biotech
Neurotech gains after company prepares to begin first-in-human clinical trials
Health & Biotech
Incannex says its experimental drug cocktail might work to treat inflammatory bowel disease
Health & Biotech
ASX pot investors now have a benchmarking tool – the Australian Cannabis Index
Health & Biotech
Cann Group lowers guidance, makes acquisition; Zelira to get new boss
Health & Biotech
MGC Pharmaceuticals launches new clinical study into brain cancer treatment
Health & Biotech
Creso Pharma enters vast new market with $2.5 million distribution agreement
Health & Biotech
Famed cannabis entrepreneur Bruce Linton explains what he sees in Creso Pharma
Health & Biotech
Althea Group ships $1m in cannabis oil to German distributor
Health & Biotech
MGC Pharma makes strong debut as London Stock Exchange’s first medicinal cannabis company
Health & Biotech
Creso Pharma brings marketing and sales of CannaQIX cannabis lozenge in-house
Health & Biotech
MGC Pharma is to become the first medicinal cannabis company to list on the London Stock Exchange
Stockhead TV
V-Con: Medical cannabis – green grass, green growth
Health & Biotech
Creso Pharma’s Canadian cannabis subsidiary picking up speed with more purchase orders
Health & Biotech
MGC Pharma is soon to be admitted to the London Stock Exchange
Load More
